AHA 2005

Levosimendan Improves Heart Failure Progression

November 16, 2005 ⋅ Post a comment
Milton Packer
Milton Packer

In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.

Click here for all the interviews from AHA 2005

Similar Interviews

  • Human Growth Hormone: Responses in Severe Heart Failure

    • Catherine Demers Recombinent human growth hormone has achieved clinical responses when used for treating heart failure. Catherine Demers of McMaster University

  • BNP Test: Key Diagnostic Step for Heart Failure (PEP Study)

    • John Cleland Maarten Simoons REFERENCE: Hot Line 1 Sunday 11:00 2 Sept, European Society of Cardiology

  • Ultrafiltration vs Diuretics for Patients with Acute Decompensated Heart Failure; UNLOAD Study Findings

    • Maria Rosa Costanzo, Edward Hospital For Heart Failure, Naperville, Il American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta.

    Post a comment

    British National Health Service is 60!»
    Virginia Berridge, Jerry Morris, Nick Mays, and Nick Black
    Virginia Berridge, Jerry Morris, Nick Mays, and Nick Black of The London School of Hygiene and Tropical Medicine
    LSHTM Audio News British National Health Service is 60! July 5th, 2008 is the 60th birthday of the British National Health Service. Peter Goodwin talks to four experts at the London School of Hygiene and Tropical Medicine to find out how it achieved the almost universal approval it enjoys in the UK, while asking what the future holds in store.
    Obesity, Car Travel, Climate Change: Linked?»
    Phil Edwards, London School of Hyugiene and Tropical Medicine
    LSHTM Audio News Obesity Linked to Motor Transport And Climate Change Peter Goodwin questions Phil Edwards of the London School of Hygiene and Tropical Medicine about "competition between stomachs and petrol tanks" discussed in a letter he and his colleague Ian Roberts have written to the medical magazine: The Lancet.
    Subscribe to Audio Medica Podcast